Gilead Sciences first launched Lenacapavir under the brand name Sunlenca in the United States and Europe markets in the year 2022
The authorization of bortezomib will enhance the company’s ability to deliver advanced cancer solutions in Southeast Asia
The special financing terms offered by United Imaging and structured by Medikabazaar to Krsnaa Diagnostics underscore the strategic importance of this alliance
Developed in consultation with clinicians and patients for an enhanced user experience
Potential of Ayurveda’s contribution in global health system through various innovative practices
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The company will also share results in two additional posters for deuruxolitinib
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Showcases specialty and sustainable materials for healthcare at Medtec China 2024
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
Studies suggest that the protein Sclerostin plays a key role in the dysregulation of bone metabolism
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
Quinidine Sulphate helps manage rare irregular heartbeat conditions
The Notes shall not be offered or sold in India
Subscribe To Our Newsletter & Stay Updated
